HealthSouth Corp (HLS) is Reiterated by Mizuho to Buy, Raises Price Target to $ 47

HealthSouth Corp (HLS) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 47 from a previous price target of $40 . Mizuho advised their investors in a research report released on Apr 29, 2016.

On the company’s financial health, HealthSouth Corp reported $0.61 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.55. The company had revenue of $909.80 million for the quarter, compared to analysts expectations of $894.01 million. The company’s revenue was up 22.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS.

HealthSouth Corp opened for trading at $39.14 and hit $41.755 on the upside on Wednesday, eventually ending the session at $41.5, with a gain of 9.27% or 3.52 points. The heightened volatility saw the trading volume jump to 23,81,420 shares. Company has a market cap of $3,726 M.

In a different news, on Mar 2, 2016, Edmund Fay (Sr. Vice Pres. and Treasurer) sold 16,240 shares at $35.50 per share price. According to the SEC, on Jan 12, 2016, John Chidsey (director) purchased 799 shares at $35.78 per share price. On Nov 16, 2015, Elissa Joy Charbonneau (Chief Medical Officer) purchased 294 shares at $33.68 per share price, according to the Form-4 filing with the securities and exchange commission.

HealthSouth Corporation (HealthSouth) is an owner and operator of inpatient rehabilitation hospitals. The Company’s inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses which include physical and cognitive disabilities or injuries due to medical conditions such as strokes hip fractures head injuries spinal cord injuries and a variety of debilitating neurological conditions. HealthSouth operates in around 33 states across the United States and in Puerto Rico and serves patients through its network of inpatient rehabilitation hospitals home health agencies and hospice agencies. The Company’s inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses. As of December 31 2014 the Company operated 107 inpatient rehabilitation hospitals. The Company’s inpatient hospitals are concentrated in the eastern half of the United States and Texas.

HealthSouth Corp

Leave a Reply

HealthSouth Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on HealthSouth Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.